<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02870855</url>
  </required_header>
  <id_info>
    <org_study_id>KYXM-201604</org_study_id>
    <nct_id>NCT02870855</nct_id>
  </id_info>
  <brief_title>Effect of Intrauterine Injection of HCG on Pregnancy Outcome in Repeated Implantation Failure Patients</brief_title>
  <official_title>Effect of Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer on Clinical Pregnancy Outcome in Repeated Implantation Failure Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Repeated implantation failure（RIF） is a insurmountable bottleneck in assisted reproductive
      technology, many studies have considered that the cause of two-thirds of implant failure is
      the decreased endometrial receptivity. Human chorionic gonadotropin (hCG) is an early
      pre-plant signal molecule secreted by the embryo, it can promote endometrial proliferation,
      increase blood flow and promote embryonic adhesion and inhibit self-regulate apoptosis of
      trophoblast cells. Previous studies showed that: intrauterine injection of HCG before embryo
      transfer can improve clinical outcomes in IVF/Intracytoplasmic sperm injection(ICSI). But
      some studies found that the intrauterine injection of HCG can not significantly improve the
      success rate of blastocyst transfer, and the reason may be the intrauterine injection of HCG
      time is too late to significantly increase the implantation rate. Would ahead of intrauterine
      injection of HCG be more effective? Thus, the patients of repeated implantation frozen embryo
      cycle according to the random principle accepted two kinds of transplants ways: ①intrauterine
      injection of HCG before blastocyst transfer; ②blastocyst transfer. Try to understand whether
      intrauterine injection of HCG can significantly improve the clinical pregnancy rate of
      blastocyst transfer in repeated implantation failure patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 28, 2017</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical pregnancy rate</measure>
    <time_frame>Until 28 day after embryo transferred</time_frame>
    <description>clinical pregnancy rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>spontaneous abortion rate</measure>
    <time_frame>until 28 day after embryo transferred</time_frame>
    <description>spontaneous abortion rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ectopic pregnancy rate</measure>
    <time_frame>until 28 day after embryo transferred</time_frame>
    <description>ectopic pregnancy rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">638</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>HCG group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intrauterine injection of HCG before blastocyst transfer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>blastocyst transfer</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intrauterine injection of HCG</intervention_name>
    <description>intrauterine injection of HCG berore blastocyst transfer</description>
    <arm_group_label>HCG group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women with unexplained RIF(two to four previous embryo transfers without achieving
             pregnancy);

          -  age＜36 years;

          -  frozen embryo transfer cycles

        Exclusion Criteria:

          -  polycystic ovary syndrome

          -  uterine abnormalities (double uterus, bicornuate uterus, unicornuate uterus and
             uterine mediastinum)

          -  intrauterine adhesions

          -  endometriosis

          -  adenomyosis

          -  hydrosalpinx

          -  uterine fibroids (submucosal fibroids, non-mucosal fibroids &gt; 4 cm and / or
             endometrial pressure)

          -  thydroid dysfunction and hyperprolactinemia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>yuan li, doctor</last_name>
    <phone>+86-731-82355100</phone>
    <email>1002251255@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Reproductive &amp; Genetic Hospital of CITIC-XIANGYA</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>yuan li</last_name>
      <phone>+86-731-82355100</phone>
      <email>1002251255@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2016</study_first_submitted>
  <study_first_submitted_qc>August 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2016</study_first_posted>
  <last_update_submitted>November 15, 2017</last_update_submitted>
  <last_update_submitted_qc>November 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chorionic Gonadotropin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

